Vastus lateralis Na+-K+-ATPase activity, protein, and isoform distribution in chronic obstructive pulmonary disease

Muscle and Nerve

Volumn 40, Issue 1, 2009, Pages 62-68

  Green, Henry James ^a   Burnett, Margaret Elizabeth ^a   D'Arsigny, Christine Linda ^b   Webb, Katherine Alexandra ^b   McBride, Ian ^b   Ouyang, Jing ^a   O'Donnell, Dennis Einan ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Cation transport; Excitation; Isoforms; Na+ K+ ATPase properties; Obstructive lung disease; Quadriceps

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ISOENZYME;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; VASTUS LATERALIS MUSCLE; WESTERN BLOTTING;

AGED; ANIMALS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUABAIN; PROTEIN ISOFORMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RATS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRITIUM;

EID: 67650230923     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21296     Document Type: Article

References (48)

1. +-ATPase activity in well trained athletes. J Appl Physiol 2005;98:186-192.
2. +-ATPase properties in rat heart and skeletal muscle 3 months after coronary artery ligation. J Appl Physiol 2004;99:656-664.
3. Barreiro E, de la Puenta B, Minguella J, Corominas JM, Serrano S, Hussain SNA, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1116-1124. (Pubitemid 40663723)
4. Bergström J, Hultman E. A study of the glycogen metabolism during exercise in man. Scand J Clin Lab Invest 1967;19:218-228.
5. +-ATPase: heterogeneity in structure, diversity and function. Am J Physiol 1998;275:F633-F650.
6. Boots AW, Haenen GRMM, Bast A. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J 2003;22(suppl):14S-27S. (Pubitemid 37351733)
7. Chibalin AV, Kovalenko M, Ryder JW, Féraille E, Wallberg-Henriksson H, Zierath JR. Insulin and glucose-induced phosphorylation α-subunits in rat skeletal muscle. Endocrinology 2001;142:3474-3482.
8. + pump regulation and skeletal muscle contractility. Physiol Rev 2003;83:1269-1324.
9. + pump. Clin Sci 1998;95:1-17.
10. Couillard A, Préfaut C. From muscle disease to myopathy to COPD: potential contribution of oxidative stress. Eur Respir J 2005;26:703-709. (Pubitemid 41448671)
11. Crambert G, Geering K. FXYD proteins: new tissue specific regulators of the ubiquitous Na, K-ATPase. Sci STKE 166 2003;1-8.
12. +-ATPase in rat skeletal muscle: content, isoform and activity characteristics. J Appl Physiol 2004;96:316-326.
13. +-ATPase activity in untrained and trained individuals. J Appl Physiol 2002;93:1650-1659.
14. +-ATPase activity in human skeletal muscle. Anal Biochem 1998;258:63-67.
15. Gosker HR, Wouters EF, van der Vusse GJ, Schols AMWJ. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-1047. (Pubitemid 30230549)
16. Gosselin N, Matecki S, Poulain M. Electrophysiologic changes during exercise testing in patients with chronic obstructive pulmonary disease. Muscle Nerve 2003;27:170-179. (Pubitemid 36169328)
17. Green HJ. Mechanisms and management of fatigue in health and disease. Can J Appl Physiol 2004;29:264-273.
18. +-ATPase pump with short-term training. J Appl Physiol 2004;97:143-148.
19. Green HJ, Bombardier E, D'Arsigny C, O'Donnell D, Ouyang J. Organization of metabolic pathways on skeletal muscle of patients with chronic obstructive lung disease. Am J Physiol Regul Integr Comp Physiol 2008;295:R935-R941.
20. Green HJ, Burnett M, D'Arsigny C, Iqbal S, O'Donnell DE, Ouyang J, et al. Muscle fiber type characteristics in females with chronic obstructive pulmonary disease? A preliminary study. J Mol Histol (to appear).
21. Green HJ, Burnett M, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol 2008;105:879-886.
22. 2+-sequestering properties in skeletal muscle in chronic obstructive lung disease. Am J Physiol 2008;295:C350-C357.
23. +-ATPase response during 16 hours of heavy intermittent cycle exercise. Am J Physiol 2007;293:E523-E530.
24. +-ATPase isoform abundance and activity with consecutive days of exercise and recovery. Am J Physiol 2008;294:E761-E767.
25. Green H, Goreham C, Ouyarg J, Ball-Burnett M, Ranney D. Regulation of fiber size, oxidative potential, and capillarization in human muscle by resistance exercise. Am J Physiol 1998;276:R591-R596.
26. +-ATPase pumps in skeletal muscle with training in normobaric hypoxia. J Appl Physiol 1999;86:1745-1748.
27. +-ATPase following a 21 day expedition to 6,194m. J Appl Physiol 2000;88:634-640.
28. + pump number and isoform expression in rats with chronic heart failure. J Appl Physiol 2003;94:2225-2236.
29. Killian KJ, Leblanc P, Martin DH, Sumners C, Jones NL, Campbell EJH. Exercise capacity and vertilatory, circulatory and symptom limitation in patients with chronic air flow limitation. Am Rev Respir Dis 1992;146:935-940.
30. Koechlin C, Couillard A, Cristol JP, Chanez P, Hayot M, Le Gallais D, et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur Respir J 2004;23:538-544.
31. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 1998;275:C1-C24. (Pubitemid 28381298)
32. +-ATPase dimer in distinct subcellular membranes from rat skeletal muscle. Biochemistry 1997;36:7726-7732.
33. Levine S, Nguyen T, Kaiser LR, Robinstein NA, Maislin G, Gregory C, et al. Human diaphragm remodelling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med 2001;168:706-713.
34. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001;2:216-224. (Pubitemid 34187929)
35. +-pump during exercise. In: Hargreaves M, Thompson M, editors. Biochemistry of exercise X. Champaign, IL: Human Kinetics; 1998. p. 71-97.
36. McKenna MJ, Medved I, Goodman CA, Brown MJ, Bjorksten AR, Murphy KT, et al. N acetylcysteine attenuates the decline in Na+-K+-ATPase pump activity and delays fatigue during prolonged exercise in humans. J Physiol 2006;576:279-288. (Pubitemid 44426236)
37. +-ATPase isoform mRNA but not protein expression in human skeletal muscle. J Physiol (Lond) 2004;556:507-519.
38. Musch TI, Terrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial interaction: rest and exercise. Am J Physiol 1992;262:H411-H419.
39. Musch TI, Wolfram S, Hageman KS, Pickar JG. Skeletal muscle ouabain binding sites are reduced in rats with chronic heart failure. J Appl Physiol 2002;92:2326-2334. (Pubitemid 34666354)
40. 3H-ouabain binding sites in biopsies of human skeletal muscle. Scand J Clin Lab Invest 1984;44:509-518.
41. +-dependent 3-O-methylfluorescein phosphatase activity. Biochem Biophys Acta 1984;770:203-209.
42. 3H] ouabain binding sites in skeletal muscle of rats with chronic heart failure. J Appl Physiol 1997;83:323-329.
43. +-ATPase in skeletal muscle: effect of aging and exercise training. J Appl Physiol 2005;99:1508-1515.
44. Schacterle GR, Pollock RL. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 1973;51:654-655.
45. Therien AG, Bolstein R. Mechanisms of sodium pump regulation. Am J Physiol 2000;279:C541-C566.
46. Troosters T, Gosselink R, Decramer M. Chronic obstructive pulmonary disease and chronic heart failure. J Cardiopul Rehabil 2004;24:137-145.
47. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008;31:492-501.
48. Wouters EFM. Muscle wasting in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:4-5.